News

Panthera Biopartners secures investment from LDC to accelerate expansion  Panthera Biopartners (“Panthera”), the UK’s largest Site Management Organisation (SMO) for commercial clinical trials, has ...
Liebherr, specialists in commercial refrigeration, is proud to introduce its new range of under-bench fridges and freezers, engineered to meet the diverse and demanding needs of modern laboratories, ...
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System AtrophyNEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a ...
PureTech Health plc PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases Former Teva North America CEO Sven Dethlefs, PhD, to lead ...
Infectious Disease Diagnostics Market OverviewThe Global Infectious Disease Diagnostics Market is valued at USD 23.1 Billion in 2024 and is projected to reach a value of USD 54.35 Billion by 2035 at a ...
Overview of the Market  The global Cystic Fibrosis Market is valued at USD 10.3 Billion in 2024 and is projected to reach a ...
The global Fitness Equipment Market is valued at USD 13.18 Billion in 2024 and is projected to reach a value of USD 22.88 ...
OverviewThe Multiple Myeloma Market is witnessing substantial growth globally, driven by increasing cancer prevalence, ...
Gene Therapy MarketThe Adeno-Associated Virus (AAV) Gene Therapy Market has emerged as a transformative segment within the ...
The heart valve devices market encompasses medical technologies used to repair or replace diseased aortic, mitral, tricuspid, ...
Funding combines equity investment and convertible loanFocus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and ...
Novel PARG inhibitor FORX-428 has shown best-in-class characteristics in preclinical studiesTrial initially taking place in the U.S., following IND clearanceInitial data expected in mid-2026 from open ...